COCCIRIL 2.5 MG/ML ORAL SUSPENSION FOR CATTLE AND SHEEP
COCCIRIL 2.5 MG/ML ORAL SUSPENSION FOR CATTLE AND SHEEP
Authorised
- Diclazuril
Product identification
Medicine name:
COCCIRIL 2.5 MG/ML ORAL SUSPENSION FOR CATTLE AND SHEEP
Active substance:
- Diclazuril
Target species:
-
Cattle (calf)
-
Sheep (lamb)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Diclazuril2.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle (calf)
-
Meat and offal0day
-
-
Sheep (lamb)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51BC03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Package description:
- White, high-density polyethylene back-pack bottle of 1 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 1 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.
- White, high-density polyethylene back-pack bottle of 5 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 5 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.
- White, high-density polyethylene hanging bottle of 250 mL closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 250 mL bottle per cardboard box together with a spigot cap.
- White, high-density polyethylene back-pack bottle of 2,5 L closed with black screw closure made of polypropylene with a polyethylene-lined sealing disk (wadding) for induction sealing inside. One 2.5 L back-pack bottle per cardboard box together with a spigot cap and back-pack strap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 43403
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0479/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 23/03/2026
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 23/03/2026